Moreover, DFFB deletion in tumor cells may attenuate killing by granzymes, as inactive DFFB is cleaved and activated by granzymes B and M. BAD/BAX deletions in tumor cells may also blunt rapid killing by granzyme B, which activates BAX and caspase-3. The gene discussed is BAX; the disease is neoplasm.